URGENT.LY INC (ULY) Fundamental Analysis & Valuation

NASDAQ:ULY • US9169312074

Current stock price

5.38 USD
+0.01 (+0.19%)
At close:
5.33 USD
-0.05 (-0.93%)
After Hours:

This ULY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ULY Profitability Analysis

1.1 Basic Checks

  • ULY had negative earnings in the past year.
  • ULY had a negative operating cash flow in the past year.
  • ULY had negative earnings in 4 of the past 5 years.
  • ULY had a negative operating cash flow in each of the past 5 years.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • ULY's Return On Assets of -58.49% is on the low side compared to the rest of the industry. ULY is outperformed by 85.61% of its industry peers.
Industry RankSector Rank
ROA -58.49%
ROE N/A
ROIC N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

  • ULY's Gross Margin of 24.35% is on the low side compared to the rest of the industry. ULY is outperformed by 79.86% of its industry peers.
  • ULY's Gross Margin has declined in the last couple of years.
  • ULY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

0

2. ULY Health Analysis

2.1 Basic Checks

  • ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ULY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • ULY has an Altman-Z score of -6.46. This is a bad value and indicates that ULY is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ULY (-6.46) is worse than 84.53% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.46
ROIC/WACCN/A
WACC10.28%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 0.34 indicates that ULY may have some problems paying its short term obligations.
  • ULY has a worse Current ratio (0.34) than 94.24% of its industry peers.
  • ULY has a Quick Ratio of 0.34. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.34, ULY is not doing good in the industry: 93.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. ULY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.97% over the past year.
EPS 1Y (TTM)58.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.33% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ULY will show a quite strong growth in Revenue. The Revenue will grow by 17.66% on average per year.
EPS Next Y71.91%
EPS Next 2Y45.41%
EPS Next 3Y35.33%
EPS Next 5YN/A
Revenue Next Year19.3%
Revenue Next 2Y17.57%
Revenue Next 3Y17.66%
Revenue Next 5YN/A

3.3 Evolution

ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -20 -40 -60 -80 -100

1

4. ULY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ULY. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ULY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • ULY's earnings are expected to grow with 35.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.41%
EPS Next 3Y35.33%

0

5. ULY Dividend Analysis

5.1 Amount

  • No dividends for ULY!.
Industry RankSector Rank
Dividend Yield 0%

ULY Fundamentals: All Metrics, Ratios and Statistics

URGENT.LY INC

NASDAQ:ULY (3/17/2026, 8:00:02 PM)

After market: 5.33 -0.05 (-0.93%)

5.38

+0.01 (+0.19%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-13
Earnings (Next)05-11
Inst Owners5.94%
Inst Owner Change-20.69%
Ins Owners3.46%
Ins Owner Change-0.22%
Market Cap11.78M
Revenue(TTM)N/A
Net Income(TTM)-25.00M
Analysts80
Price Target6.89 (28.07%)
Short Float %6.05%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.54%
Min EPS beat(2)-65.02%
Max EPS beat(2)-50.07%
EPS beat(4)0
Avg EPS beat(4)-75.68%
Min EPS beat(4)-121.92%
Max EPS beat(4)-50.07%
EPS beat(8)2
Avg EPS beat(8)46.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-0.44%
Max Revenue beat(4)1.2%
Revenue beat(8)4
Avg Revenue beat(8)1.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-41.3%
PT rev (3m)-41.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.92
EYN/A
EPS(NY)-4.19
Fwd EYN/A
FCF(TTM)-5.9
FCFYN/A
OCF(TTM)-3.47
OCFYN/A
SpS58.42
BVpS-20.64
TBVpS-25.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.35%
FCFM N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
F-Score4
Asset Turnover2.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 127.92%
Cap/Sales 4.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -6.46
F-Score4
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)63.32%
Cap/Depr(5y)101.16%
Cap/Sales(3y)2.81%
Cap/Sales(5y)25.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.74%
EPS Next Y71.91%
EPS Next 2Y45.41%
EPS Next 3Y35.33%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.94%
Revenue Next Year19.3%
Revenue Next 2Y17.57%
Revenue Next 3Y17.66%
Revenue Next 5YN/A
EBIT growth 1Y76.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.34%
EBIT Next 3Y34.58%
EBIT Next 5YN/A
FCF growth 1Y12.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.42%
OCF growth 3YN/A
OCF growth 5YN/A

URGENT.LY INC / ULY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for URGENT.LY INC?

ChartMill assigns a fundamental rating of 1 / 10 to ULY.


What is the valuation status for ULY stock?

ChartMill assigns a valuation rating of 1 / 10 to URGENT.LY INC (ULY). This can be considered as Overvalued.


Can you provide the profitability details for URGENT.LY INC?

URGENT.LY INC (ULY) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ULY stock?

The Earnings per Share (EPS) of URGENT.LY INC (ULY) is expected to grow by 71.91% in the next year.